Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.51
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Join SI Premium – FREE
Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.51, versus $0.51 reported last year. Revenue for the quarter came in at $599 million, versus $581 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
